/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.
VIENNA, Dec. 10, 2021 /PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids in horses.
/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.
Genetically altered flu virus successfully knocked back sarcoids in horses horsetalk.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from horsetalk.co.nz Daily Mail and Mail on Sunday newspapers.